Chemed Financial Statements
NYSE: CHEHealth CareMedical/Nursing ServicesUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pre-market: 498.00 -0.05%
Chemed revenue and earnings
In fiscal 2025, Chemed generated $2.53 billion in revenue, up 4.1% from fiscal 2024, its 3rd consecutive year of revenue growth. Net income was $265.2 million (-12.2% year over year), for a net margin of 10.5% versus a median of 12.4% in the prior 5 years. Gross margin was 32.5% (down from 35.1%) and operating margin 13.4%.
Diluted earnings per share came in at $18.34, down from $19.89. Over the last 5 fiscal years, CHE's revenue has grown at a 4.0% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
Chemed income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.53B | 2.43B | 2.26B | 2.13B | 2.14B | 2.08B | 1.94B | 1.78B | 1.67B | 1.58B |
| Revenue growth (YoY) | +4.06% | +7.37% | +6.06% | -0.20% | +2.87% | +7.27% | +8.75% | +6.96% | +5.70% | +2.17% |
| Cost of Revenue | 1.71B | 1.58B | 1.47B | 1.37B | 1.37B | 1.38B | 1.32B | 1.23B | 1.15B | 1.12B |
| Gross Profit | 823.18M | 854.35M | 798.82M | 765.09M | 769.80M | 701.39M | 617.43M | 555.00M | 516.19M | 461.45M |
| Operating Expenses | 2.19B | 2.06B | 1.92B | 1.79B | 426.76M | 311.71M | 360.05M | 311.37M | 403.16M | 282.70M |
| Selling, General & Admin | 417.19M | 424.36M | 395.12M | 358.73M | 366.73M | 330.22M | 305.71M | 271.21M | 276.65M | 243.57M |
| Operating Income | 338.25M | 366.49M | 340.57M | 343.50M | 343.04M | 389.68M | 257.38M | 243.63M | 113.03M | 178.75M |
| Interest Expense | 1.75M | 1.78M | 3.11M | 4.58M | 1.87M | 2.35M | 4.54M | 4.99M | 4.27M | 3.71M |
| Other Income (Expense) | 19.28M | 34.75M | 12.91M | -9.23M | 9.14M | 8.66M | 8.76M | 958.00K | 8.15M | 2.02M |
| Pretax Income | 355.78M | 399.46M | 350.37M | 329.68M | 350.31M | 395.99M | 261.61M | 239.60M | 116.92M | 177.05M |
| Income Tax | 90.54M | 97.47M | 77.86M | 80.06M | 81.76M | 76.52M | 41.69M | 34.06M | 18.74M | 68.31M |
| Net Income | 265.24M | 302.00M | 272.51M | 249.62M | 268.55M | 319.47M | 219.92M | 205.54M | 98.18M | 108.74M |
| Net Income growth (YoY) | -12.17% | +10.82% | +9.17% | -7.05% | -15.94% | +45.26% | +7.00% | +109.36% | -9.72% | -1.39% |
| EPS (Basic) | 18.42 | 20.10 | 18.11 | 16.72 | 17.14 | 20.02 | 13.77 | 12.80 | 6.11 | 6.64 |
| EPS (Diluted) | 18.34 | 19.89 | 17.93 | 16.53 | 16.85 | 19.48 | 13.31 | 12.23 | 5.86 | 6.48 |
| Shares Outstanding (Basic) | 14.40M | 15.02M | 15.05M | 14.93M | 15.67M | 15.96M | 15.97M | 16.06M | 16.06M | 16.38M |
| Shares Outstanding (Diluted) | 14.46M | 15.19M | 15.20M | 15.10M | 15.94M | 16.40M | 16.53M | 16.80M | 16.74M | 16.79M |
| EBITDA | 403.09M | 429.54M | 401.43M | 402.67M | 402.09M | 446.26M | 302.58M | 282.50M | 148.66M | 213.39M |
| Gross Margin | 32.54% | 35.14% | 35.28% | 35.84% | 35.98% | 33.73% | 31.85% | 31.13% | 30.97% | 29.26% |
| Operating Margin | 13.37% | 15.07% | 15.04% | 16.09% | 16.04% | 18.74% | 13.28% | 13.67% | 6.78% | 11.34% |
| Net Margin | 10.48% | 12.42% | 12.03% | 11.69% | 12.55% | 15.36% | 11.34% | 11.53% | 5.89% | 6.90% |
This table shows 10 annual periods of Chemed's income statement, from FY 2025 back to FY 2016, across 19 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow CHE's reporting calendar. What is a income statement?